Fatty Amides
Products Related to Fatty Amides(65)
- GC18506N-Arachidonoyl DopamineCAS: 199875-69-9Purity: >98.50%
N-Arachidonoyl Dopamin ist ein potenter und selektiver endogener CB1-Rezeptoragonist mit einem Ki von 250 nM.
- GC18615Arachidonoyl CyclopropylamideCAS: 229021-64-1Purity: >98.00%
Arachidonoyl-Cyclopropylamid (ACPA) ist ein potenter und selektiver Agonist des Cannabinoid-Rezeptors 1 (CB1) mit Ki-Werten von 2,2 bzw. 715 nM für CB1- und CB2-Rezeptoren.
- GC40297R-2 MethanandamideCAS: 157182-47-3Purity: >98.00%
R-2 methanandamide is a cannabinoid analog with a methyl group in the (R) configuration at C-2 of the ethanolamine group.
- GC40408Glycerophospho-N-Palmitoyl EthanolamineCAS: 100575-09-5Purity: >98.00%
N-Acylated ethanolamines (NAE) are naturally-occurring lipids that have diverse bioactivities.
- GC41487Heptadecanoyl EthanolamideCAS: 53832-59-0Purity: >98.00%
Palmitoyl ethanolamide (PEA) is an endogenous cannabinoid found in brain, liver, and other mammalian tissues.
- GC41650(±)14(15)-EET EthanolamidePurity: >95.00%
Arachidonyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
- GC41659(±)-2-Methyl Arachidonoyl-2'-FluoroethylamideCAS: 166100-39-6Purity: >95.00%
(±)-2-Methyl arachidonoyl-2'-fluoroethylamide (2-Methyl-2'-fluoro AEA) is an analog of anandamide (AEA) in which the alcohol of the ethanolamide group has been removed and replaced with a fluorine atom.
- GC41662(±)5(6)-EET EthanolamidePurity: >95.00%
Arachidonyl ethanolamide is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
- GC41665(±)8(9)-EET EthanolamidePurity: >98.00%
Arachidonoyl ethanolamide (AEA; anandamide) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
- GC41705(R)-(-)-Docosahexaenyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41706(R)-(-)-Eicosapentaenyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41708(R)-(-)-Linoleyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41710(R)-(+)-Eicosapentaenyl-1'-Hydroxy-2'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41724(S)-(-)-Docosahexaenyl-1'-Hydroxy-2'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41725(S)-(-)-Eicosapentaenyl-1'-Hydroxy-2'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41726(S)-(-)-Linoleyl-1'-Hydroxy-2'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41728(S)-(+)-Docosahexaenyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41729(S)-(+)-Eicosapentaenyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41731(S)-(+)-Linoleyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC4208520-hydroxy N-Arachidonoyl TaurinePurity: >95.00%
Arachidonic acid is metabolized by cytochrome P450 (CYP450) 4A ω-hydroxylase to 20-HETE, which acts as a vasoconstrictor in the kidney and brain.
- GC424805(Z),8(Z),11(Z)-Eicosatrienoic Acid EthanolamideCAS: 169232-04-6Purity: >98.00%
5(Z),8(Z),11(Z)-Eicosatrienoic acid ethanolamide is essentially identical to AEA in its agonist binding to CB1 and CB2 receptors.
- GC42839Arachidonoyl Ethanolamide PhosphateCAS: 183323-26-4Purity: >98.00%
Arachidonoyl ethanolamide was the first endogenous cannabinoid (CB) to be isolated and characterized as an agonist acting on the same receptors (CB1 and CB2) as δ9-THC.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GA23211 | Myristoyl-Gly-OH | 14246-55-0 | >97.00% | |
A lipidated amino acid | ||||
| GC18506 | N-Arachidonoyl Dopamine | 199875-69-9 | >98.50% | |
N-Arachidonoyl Dopamin ist ein potenter und selektiver endogener CB1-Rezeptoragonist mit einem Ki von 250 nM. | ||||
| GC18615 | Arachidonoyl Cyclopropylamide | 229021-64-1 | >98.00% | |
Arachidonoyl-Cyclopropylamid (ACPA) ist ein potenter und selektiver Agonist des Cannabinoid-Rezeptors 1 (CB1) mit Ki-Werten von 2,2 bzw. 715 nM für CB1- und CB2-Rezeptoren. | ||||
| GC18719 | Docosatetraenoyl Ethanolamide | 150314-35-5 | >98.00% | |
An endocannabinoid | ||||
| GC40297 | R-2 Methanandamide | 157182-47-3 | >98.00% | |
R-2 methanandamide is a cannabinoid analog with a methyl group in the (R) configuration at C-2 of the ethanolamine group. | ||||
| GC40408 | Glycerophospho-N-Palmitoyl Ethanolamine | 100575-09-5 | >98.00% | |
N-Acylated ethanolamines (NAE) are naturally-occurring lipids that have diverse bioactivities. | ||||
| GC41487 | Heptadecanoyl Ethanolamide | 53832-59-0 | >98.00% | |
Palmitoyl ethanolamide (PEA) is an endogenous cannabinoid found in brain, liver, and other mammalian tissues. | ||||
| GC41650 | (±)14(15)-EET Ethanolamide | - | >95.00% | |
Arachidonyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. | ||||
| GC41659 | (±)-2-Methyl Arachidonoyl-2'-Fluoroethylamide | 166100-39-6 | >95.00% | |
(±)-2-Methyl arachidonoyl-2'-fluoroethylamide (2-Methyl-2'-fluoro AEA) is an analog of anandamide (AEA) in which the alcohol of the ethanolamide group has been removed and replaced with a fluorine atom. | ||||
| GC41662 | (±)5(6)-EET Ethanolamide | - | >95.00% | |
Arachidonyl ethanolamide is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. | ||||
| GC41665 | (±)8(9)-EET Ethanolamide | - | >98.00% | |
Arachidonoyl ethanolamide (AEA; anandamide) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. | ||||
| GC41705 | (R)-(-)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41706 | (R)-(-)-Eicosapentaenyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41708 | (R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41710 | (R)-(+)-Eicosapentaenyl-1'-Hydroxy-2'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41724 | (S)-(-)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41725 | (S)-(-)-Eicosapentaenyl-1'-Hydroxy-2'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41726 | (S)-(-)-Linoleyl-1'-Hydroxy-2'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41728 | (S)-(+)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41729 | (S)-(+)-Eicosapentaenyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41731 | (S)-(+)-Linoleyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC42085 | 20-hydroxy N-Arachidonoyl Taurine | - | >95.00% | |
Arachidonic acid is metabolized by cytochrome P450 (CYP450) 4A ω-hydroxylase to 20-HETE, which acts as a vasoconstrictor in the kidney and brain. | ||||
| GC42480 | 5(Z),8(Z),11(Z)-Eicosatrienoic Acid Ethanolamide | 169232-04-6 | >98.00% | |
5(Z),8(Z),11(Z)-Eicosatrienoic acid ethanolamide is essentially identical to AEA in its agonist binding to CB1 and CB2 receptors. | ||||
| GC42839 | Arachidonoyl Ethanolamide Phosphate | 183323-26-4 | >98.00% | |
Arachidonoyl ethanolamide was the first endogenous cannabinoid (CB) to be isolated and characterized as an agonist acting on the same receptors (CB1 and CB2) as δ9-THC. | ||||